tiprankstipranks
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market

Kymera Therapeutics (KYMR) Income Statement

Compare
222 Followers

Kymera Therapeutics Income Statement

Last quarter (Q4 2024), Kymera Therapeutics's total revenue was $7.39M, a decrease of -84.56% from the same quarter last year. In Q4, Kymera Therapeutics's net income was $-70.75M. See Kymera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 47.07M$ 78.59M$ 46.83M$ 72.83M$ 34.03M
Gross Profit
$ 47.07M$ -110.49M$ 43.85M$ 70.44M$ -28.07M
Operating Expenses
$ 308.71M$ 244.12M$ 208.08M$ 173.36M$ 80.34M
Depreciation and Amortization
$ 7.37M$ 3.56M$ 2.98M$ 2.40M$ 1.76M
EBITDA
$ -216.24M$ -143.20M$ -151.66M$ -97.64M$ -43.72M
Operating Income
$ -261.63M$ -165.53M$ -161.26M$ -100.53M$ -46.30M
Other Income/Expenses
$ 37.78M$ 18.57M$ 6.45M$ 313.00K$ 711.00K
Pretax Income
$ -223.86M$ -146.96M$ -154.81M$ -100.22M$ -45.59M
Net Income
$ -223.86M$ -146.96M$ -151.83M$ -98.00M$ -43.95M
Per Share Metrics
Basic EPS
$ -2.98$ -2.52$ -2.82$ -2.04$ -2.53
Diluted EPS
$ -2.98$ -2.52$ -2.82$ -2.04$ -2.53
Weighted Average Shares Outstanding
75.04M 58.37M 53.93M 47.99M 17.35M
Weighted Average Shares Outstanding (Diluted)
75.04M 58.37M 53.93M 47.99M 17.35M
Currency in USD

Kymera Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis